 | Day One Biopharmaceuticals, Inc | |||
| NMS : DAWN || Location: United States | ||||
$13.21-1.98 (-13.03%) |
3.78 M | 13.02 - 14.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 8.942 M |
| March 28, 2024 | 8.985 M |
| March 15, 2024 | 9.609 M |
| Feb. 29, 2024 | 9.703 M |
| Feb. 15, 2024 | 9.715 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.60 | -0.64 | -7.56% |
| 09/30/2023 | -0.61 | -0.54 | 12.11% |
| 06/30/2023 | -0.62 | -0.61 | 1.98% |
| 03/31/2023 | -0.60 | -0.59 | 2.33% |
| 12/31/2022 | -0.58 | -0.56 | 3.11% |
DAWN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 87.377M | Shares Float | 54.603M |
| Short Float | 8.942M | Market Cap | 1154.25M |
| Institution ownership | 89.21% | Insider ownership | 19.853% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.37 | Forward EPS | -1.97 |